Nanjing Pharmaceutical Group Company Limited Class ASSE: 600713

"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Outline of the 2026 Semi-annual Performance Briefing

Sep 18, 2026 · Issued by Nanjing Pharmaceutical Group Company Limited Class A via Shanghai Stock Exchange

Announcement on Outline of the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Nanjing Pharmaceutical Group Company Limited Class A

"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026Sep 16
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Implementation of Dividend Distribution for the First Half of 2026Sep 10
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Redemption upon Maturity of Cash Management Products Purchased with Certain Temporarily Idle Raised Funds and Continued Cash Management by the Company and Its SubsidiarySep 9
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Convening the 2026 Semi-annual Performance BriefingSep 8

All Nanjing Pharmaceutical Group Company Limited Class A news releases